| Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease M Masarone, V Rosato, M Dallio, AG Gravina, A Aglitti, C Loguercio, ... Oxidative medicine and cellular longevity 2018 (1), 9547613, 2018 | 614 | 2018 |
| The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis B Palmentieri, I De Sio, V La Mura, M Masarone, R Vecchione, S Bruno, ... Digestive and Liver Disease 38 (7), 485-489, 2006 | 424 | 2006 |
| Non alcoholic fatty liver: epidemiology and natural history M Masarone, A Federico, L Abenavoli, C Loguercio, M Persico Reviews on recent clinical trials 9 (3), 126-133, 2014 | 343 | 2014 |
| Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea AG Gravina, A Federico, E Ruocco, AL Schiavo, M Masarone, C Tuccillo, ... United European gastroenterology journal 3 (1), 17-24, 2015 | 136 | 2015 |
| NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome V Rosato, M Masarone, M Dallio, A Federico, A Aglitti, M Persico International journal of environmental research and public health 16 (18), 3415, 2019 | 134 | 2019 |
| Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage M Masarone, V Rosato, A Aglitti, T Bucci, R Caruso, T Salvatore, ... PLoS one 12 (6), e0178473, 2017 | 108 | 2017 |
| Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study G Guiotto, M Masarone, F Paladino, E Ruggiero, S Scott, S Verde, ... Intensive care medicine 36, 692-696, 2010 | 94 | 2010 |
| Efficacy and safety of new direct antiviral agents in hepatitis C virus–infected patients with diffuse large B‐cell non‐Hodgkin's lymphoma M Persico, A Aglitti, R Caruso, A De Renzo, C Selleri, C Califano, ... Hepatology 67 (1), 48-55, 2018 | 89 | 2018 |
| Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 L Abenavoli, M Masarone, V Peta, N Milic, N Kobyliak, S Rouabhia, ... World journal of gastroenterology: WJG 20 (41), 15233, 2014 | 89 | 2014 |
| Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma V La Mura, A De Renzo, F Perna, D D’Agostino, M Masarone, M Romano, ... Journal of hepatology 49 (4), 557-563, 2008 | 86 | 2008 |
| The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. A Federico, M Dallio, M Masarone, M Persico, C Loguercio European Review for Medical & Pharmacological Sciences 20 (22), 2016 | 85 | 2016 |
| Lung ultrasound for diagnosis of pneumonia in emergency department A Pagano, FG Numis, G Visone, C Pirozzi, M Masarone, M Olibet, R Nasti, ... Internal and emergency medicine 10, 851-854, 2015 | 77 | 2015 |
| Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease A Federico, C Zulli, I De Sio, A Del Prete, M Dallio, M Masarone, ... World Journal of Gastroenterology: WJG 20 (45), 16841, 2014 | 77 | 2014 |
| Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years M Persico, S Perrotta, E Persico, L Terracciano, A Folgori, L Ruggeri, ... Journal of viral hepatitis 13 (5), 290-296, 2006 | 77 | 2006 |
| The role of resveratrol in liver disease: A comprehensive review from in vitro to clinical trials C Izzo, M Annunziata, G Melara, R Sciorio, M Dallio, M Masarone, ... Nutrients 13 (3), 933, 2021 | 73 | 2021 |
| Epidemiology and natural history of alcoholic liver disease M Masarone, V Rosato, M Dallio, L Abenavoli, A Federico, C Loguercio, ... Reviews on recent clinical trials 11 (3), 167-174, 2016 | 70 | 2016 |
| Interleukin-10− 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection M Persico, M Capasso, E Persico, M Masarone, A De Renzo, D Spano, ... Journal of hepatology 45 (6), 779-785, 2006 | 69 | 2006 |
| Non alcoholic fatty liver disease and eNOS dysfunction in humans M Persico, M Masarone, A Damato, M Ambrosio, A Federico, V Rosato, ... BMC gastroenterology 17, 1-9, 2017 | 67 | 2017 |
| Role of bisphenol A as environmental factor in the promotion of non‐alcoholic fatty liver disease: in vitro and clinical study M Dallio, M Masarone, S Errico, AG Gravina, C Nicolucci, R Di Sarno, ... Alimentary pharmacology & therapeutics 47 (6), 826-837, 2018 | 61 | 2018 |
| Evaluation of the effect derived from silybin with vitamin D and vitamin E administration on clinical, metabolic, endothelial dysfunction, oxidative stress parameters, and … A Federico, M Dallio, M Masarone, AG Gravina, R Di Sarno, C Tuccillo, ... Oxidative Medicine and Cellular Longevity 2019 (1), 8742075, 2019 | 59 | 2019 |
Marcello PERSICOProfessore Ordinario Medicina Interna Università di Salerno在 unisa.it 的电子邮件经过验证
